Internal Medicine, Cardiovascular Disease · Manassas, VA
NPI
1952358087
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
8100 Ashton Ave, Suite 200
Manassas, VA, 20109
Phone (703) 331-0300
Groups this clinician bills Medicare through
Medicare paid, 2024
$555K
4,095 services
Medicare patients, 2024
1,258
Average age 77
Drug cost, 2024
$2.2M
5,997 prescriptions
Company payments, 2025
$4,607
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Khalid Abousy was code 99214 (office e&m - established), 1,000 times for 518 patients. In total Khalid Abousy billed 4,095 services in 53 codes, and Medicare paid $555K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,000 | 518 | $94.27 | $94K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 360 | 90 | $6.40 | $2,302 |
| 93000 Electrocardiogram | Office | 350 | 299 | $11.30 | $3,956 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 348 | 100 | $48.35 | $17K |
| 93306 Echocardiography (TTE/TEE) | Office | 269 | 264 | $144.83 | $39K |
| 93306 Echocardiography (TTE/TEE) | Facility | 202 | 199 | $50.68 | $10K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 187 | 186 | $139.83 | $26K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 137 | 88 | $340.89 | $47K |
| 99233 Hospital E&M - Subsequent | Facility | 116 | 108 | $94.54 | $11K |
| 93015 Electrocardiogram | Office | 95 | 95 | $55.82 | $5,303 |
| 99442 Telephone Services | Office | 93 | 85 | $71.96 | $6,692 |
| 78431 Myocardial Perfusion Scan | Office | 88 | 88 | $1,996.08 | $176K |
| 99223 Hospital E&M - Initial | Facility | 83 | 82 | $134.30 | $11K |
| 93922 Duplex Scan - Extremity Arteries | Office | 74 | 73 | $61.92 | $4,582 |
| 99441 Telephone Services | Office | 61 | 56 | $42.38 | $2,585 |
By year: 2022 $555K for 3,960 services; 2023 $604K for 3,789 services; 2024 $555K for 4,095 services.
Medicare prescription drug claims, 2024
In 2024, the drug Khalid Abousy prescribed most often to Medicare patients was Rosuvastatin Calcium, with 630 prescriptions and refills. In total Khalid Abousy wrote 5,997 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 630 | 1,690 | 220 | $9,902 |
| Metoprolol Succinate Generic | 400 | 1,094 | 152 | $5,286 |
| Ezetimibe Generic | 378 | 1,068 | 141 | $9,404 |
| Atorvastatin Calcium Generic | 346 | 998 | 125 | $3,067 |
| Valsartan Generic | 286 | 751 | 97 | $6,755 |
| Ozempic Semaglutide | 260 | 408 | 55 | $394K |
| Amlodipine Besylate Generic | 250 | 675 | 90 | $1,306 |
| Xarelto Rivaroxaban | 240 | 592 | 86 | $315K |
| Entresto Sacubitril/Valsartan | 228 | 520 | 69 | $335K |
| Clopidogrel Clopidogrel Bisulfate | 223 | 571 | 78 | $2,515 |
| Labetalol Hcl Generic | 206 | 546 | 69 | $5,317 |
| Olmesartan Medoxomil Generic | 203 | 577 | 80 | $3,329 |
| Eliquis Apixaban | 164 | 339 | 55 | $189K |
| Furosemide Generic | 160 | 401 | 72 | $683 |
| Repatha Sureclick Evolocumab | 150 | 291 | 43 | $163K |
Brand drugs: 1,620 claims; generic drugs: 4,377 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Khalid Abousy $4,607 ($4,607 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novartis Pharmaceuticals Corporation with $522.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 23 | $522 |
| CVRx, Inc. CVRX | 9 | $476 |
| Scpharmaceuticals Inc. SCPH | 12 | $448 |
| E.R. Squibb & Sons, L.L.C. BMY | 9 | $272 |
| Merck Sharp & Dohme LLC MRK | 14 | $251 |
| Novo Nordisk Inc NVO | 8 | $247 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $226 |
| Recor Medical Inc | 4 | $212 |
| Amgen Inc. AMGN | 6 | $196 |
| Lilly USA, LLC LLY | 4 | $193 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.